Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ASCL2 | hg19_v2_chr11_-_2292182_2292212 | 0.19 | 2.9e-01 | Click! |
TCF12 | hg19_v2_chr15_+_57211318_57211355 | -0.18 | 3.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_39258461 Show fit | 8.43 |
ENST00000440582.1
|
keratin associated protein 4-16, pseudogene |
|
chr22_+_22730353 Show fit | 8.29 |
ENST00000390296.2
|
immunoglobulin lambda variable 5-45 |
|
chr16_+_23847267 Show fit | 8.27 |
ENST00000321728.7
|
protein kinase C, beta |
|
chr1_+_27668505 Show fit | 7.01 |
ENST00000318074.5
|
synaptotagmin-like 1 |
|
chr16_+_23847339 Show fit | 7.01 |
ENST00000303531.7
|
protein kinase C, beta |
|
chr5_-_176936844 Show fit | 6.66 |
ENST00000510380.1
ENST00000510898.1 ENST00000357198.4 |
docking protein 3 |
|
chr22_-_37882395 Show fit | 6.40 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
chr22_+_22707260 Show fit | 6.38 |
ENST00000390293.1
|
immunoglobulin lambda variable 5-48 (non-functional) |
|
chr16_+_23847355 Show fit | 6.10 |
ENST00000498058.1
|
protein kinase C, beta |
|
chr5_-_176936817 Show fit | 5.64 |
ENST00000502885.1
ENST00000506493.1 |
docking protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 93.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.9 | 76.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.6 | 76.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 23.6 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.1 | 21.5 | GO:0002250 | adaptive immune response(GO:0002250) |
5.3 | 21.4 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
3.1 | 15.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 15.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.2 | 13.5 | GO:0042100 | B cell proliferation(GO:0042100) |
0.4 | 10.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 74.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 40.0 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 29.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.7 | 25.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 17.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 15.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 13.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 12.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 11.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 11.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 150.0 | GO:0003823 | antigen binding(GO:0003823) |
1.2 | 78.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 26.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
5.3 | 21.4 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.2 | 20.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
5.1 | 15.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.3 | 12.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.7 | 11.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.9 | 10.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 10.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 44.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.0 | 27.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 27.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 21.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 17.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 12.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 9.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 9.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 9.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 9.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 30.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 25.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 22.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 21.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 20.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 16.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 12.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 11.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 9.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 8.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |